MedTrace Logo

Neurodevelopmental Outcomes in Cerebral Visual Impairment

NCT07212010 · Status: ENROLLING_BY_INVITATION · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2025-10-09

No results posted yet for this study

Summary

Cerebral visual impairment (CVI) is one of the leading causes of pediatric visual impairment and negatively impacts the development of motor, language, and cognitive skills. This study proposes to (1) establish a novel and easy to use CVI screening algorithm for infants and (2) develop CVI subtypes based on vision, motor, language, and cognition. The overarching goal is to identify CVI early and enhance our comprehension of CVI's impact on a child's development. The results will fundamentally change the approach to designing treatments for children with CVI.

Conditions

  • Cerebral Visual Impairment

Sponsors & Collaborators

  • National Eye Institute (NEI)

    collaborator NIH

  • Children's Hospital Medical Center, Cincinnati

    lead OTHER

Principal Investigators

  • Karen L Harpster, PhD, OTR/L · Cincinnati Childrens Hospital Medical Center

  • Veeral Shah, MD · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
6 Months
Max Age
72 Months
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-31
Primary Completion
2030-08-31
Completion
2031-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07212010 on ClinicalTrials.gov